Common blood pressure pill may fight fatty liver and cancer risk
NCT ID NCT04550481
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This study tests whether lisinopril, a common blood pressure medication, can prevent liver damage from getting worse in people with non-alcoholic fatty liver disease (NAFLD). About 45 adults with advanced liver scarring will take lisinopril for a period, and researchers will measure changes in liver health markers. The goal is to see if this drug can reduce the risk of liver cancer and slow disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONALCOHOLIC STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.